ABBOTINDIA 29080.00 +378.50(1.32%)
ADANIGREEN 1540.50 -16.95(-1.09%)
ADANIPORTS 1338.15 -9.10(-0.68%)
AMBUJACEM 559.65 -1.20(-0.21%)
APOLLOHOSP 7100.00 -59.30(-0.83%)
ASHOKLEY 224.35 +2.35(1.06%)
ASIANPAINT 2480.30 -62.35(-2.45%)
ASTRAL 1740.85 +26.85(1.57%)
AUBANK 575.65 -5.00(-0.86%)
AUROPHARMA 1263.85 -24.00(-1.86%)
AXISBANK 1158.35 -12.35(-1.05%)
BAJAJ-AUTO 9708.00 -206.20(-2.08%)
BAJAJFINSV 1706.55 -11.05(-0.64%)
BAJAJHLDNG 10839.00 +332.65(3.17%)
BAJFINANCE 6642.40 -137.85(-2.03%)
BANDHANBNK 173.25 -1.95(-1.11%)
BANKBARODA 253.75 -4.60(-1.78%)
BERGEPAINT 496.05 +4.60(0.94%)
BHARATFORG 1370.45 -26.10(-1.87%)
BHARTIARTL 1568.00 +7.85(0.50%)
BOSCHLTD 34350.00 -615.30(-1.76%)
BPCL 312.25 -0.30(-0.10%)
BRITANNIA 5042.25 -383.05(-7.06%)
CHOLAFIN 1243.10 -18.70(-1.48%)
CIPLA 1563.35 -28.40(-1.78%)
COALINDIA 421.45 -2.45(-0.58%)
COFORGE 8114.20 +50.80(0.63%)
COLPAL 2816.40 -55.65(-1.94%)
CONCOR 821.20 -9.50(-1.14%)
CUMMINSIND 3519.15 -138.90(-3.80%)
DABUR 520.20 -2.75(-0.53%)
DIVISLAB 5825.30 -68.50(-1.16%)
DMART 3807.35 -79.00(-2.03%)
DRREDDY 1276.80 -11.40(-0.88%)
DLF 778.30 -7.50(-0.95%)
EICHERMOT 4750.60 -38.20(-0.80%)
FEDERALBNK 207.50 -0.25(-0.12%)
GAIL 195.55 -7.45(-3.67%)
GODREJCP 1219.60 -31.05(-2.48%)
GODREJPROP 2666.30 -18.40(-0.69%)
GRASIM 2525.60 +5.80(0.23%)
HAVELLS 1624.70 -17.85(-1.09%)
HDFCAMC 4485.00 +33.15(0.74%)
HDFCBANK 1717.00 -49.60(-2.81%)
HDFCLIFE 700.65 -4.60(-0.65%)
HEROMOTOCO 4737.15 -19.00(-0.40%)
HCLTECH 1875.55 +8.55(0.46%)
HINDALCO 653.95 -1.25(-0.19%)
HINDPETRO 376.80 -4.40(-1.15%)
HINDUNILVR 2481.00 -9.65(-0.39%)
ICICIBANK 1270.00 +0.85(0.07%)
ICICIGI 1898.15 -25.10(-1.31%)
ICICIPRULI 701.75 -2.60(-0.37%)
IDEA 7.75 -0.08(-1.02%)
IDFCFIRSTB 66.54 +0.89(1.36%)
INDHOTEL 729.40 -0.05(-0.01%)
INDUSINDBK 1061.50 +0.45(0.04%)
INFY 1872.35 +12.35(0.66%)
ITC 476.20 -0.50(-0.10%)
JSWSTEEL 961.15 -17.55(-1.79%)
JUBLFOOD 640.25 +38.40(6.38%)
KOTAKBANK 1734.55 -9.90(-0.57%)
LT 3625.65 -1.70(-0.05%)
LTTS 5099.10 +0.50(0.01%)
LUPIN 2109.85 +5.55(0.26%)
M&M 2896.20 -33.95(-1.16%)
MARICO 595.90 -20.90(-3.39%)
MARUTI 11190.00 -214.95(-1.88%)
MPHASIS 2857.65 -0.45(-0.02%)
MRF 124600.00 +5314.40(4.46%)
MUTHOOTFIN 1792.45 -24.70(-1.36%)
NAUKRI 7847.80 -102.55(-1.29%)
NESTLEIND 2269.00 -10.00(-0.44%)
NMDC 226.40 -6.55(-2.81%)
NTPC 385.35 -7.10(-1.81%)
ONGC 257.15 +0.25(0.10%)
PAGEIND 47139.05 -195.20(-0.41%)
PEL 1029.40 -7.30(-0.70%)
PERSISTENT 5703.00 -18.40(-0.32%)
PGHH 15650.00 +67.25(0.43%)
PIDILITIND 3094.35 -3.65(-0.12%)
PIIND 4565.25 -30.95(-0.67%)
PNB 104.12 -1.00(-0.95%)
PNBHOUSING 977.00 +11.00(1.14%)
POLYCAB 6656.70 -45.95(-0.69%)
POWERGRID 328.30 -1.45(-0.44%)
RELIANCE 1276.85 +3.80(0.30%)
SBICARD 686.50 -6.10(-0.88%)
SBILIFE 1571.90 +5.65(0.36%)
SBIN 828.40 -19.40(-2.29%)
SHREECEM 24444.05 -107.85(-0.44%)
SIEMENS 7047.50 -118.35(-1.65%)
SRF 2273.25 -20.05(-0.87%)
SUNPHARMA 1806.40 +11.50(0.64%)
TATACONSUM 984.25 +8.20(0.84%)
TATACHEM 1100.35 +3.85(0.35%)
TATAMOTORS 786.05 -18.70(-2.32%)
TATAPOWER 415.75 -15.75(-3.65%)
TATASTEEL 145.15 +0.20(0.14%)
TCS 4200.15 +5.10(0.12%)
TECHM 1698.40 -4.90(-0.29%)
TORNTPHARM 3144.55 -7.35(-0.23%)
TTML 70.37 +0.03(0.04%)
ULTRACEMCO 10945.00 -23.00(-0.21%)
UBL 1928.70 -3.95(-0.20%)
UPL 535.50 +20.40(3.96%)
VEDL 447.50 -8.00(-1.76%)
VOLTAS 1765.30 +12.45(0.71%)
WIPRO 572.50 +0.25(0.04%)
YESBANK 19.90 -0.01(-0.05%)
ZEEL 120.45 -0.25(-0.21%)
ZYDUSLIFE 951.00 -17.55(-1.81%)

Cravatex ‘s Q1 Report: Revenue Falls by 54.46% YoY

Image is loading

Highlights

  • The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
  • Sales over the Year and quarter: The company’s sales declined by -54.46 % over the year, decrease in net sales/revenue by -49.14 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 120.47 %. Marginal increase in other income during this quarter, up by 29.91%.
  • Profit over the Year and quarter: Significant improvement in profitability for Cravatex Ltd.. Notable increase of 14.15 % in net profit Year to Year, Cravatex Ltd.’s profitability dropped by -3.97 % Quarter to Quarter.
  • EPS over the Year and quarter: EPS increased by 14.02 % Year to Year. EPS decreased by -4.1 % in previous quarter. Analysis needed for shareholder value.

The comprehensive analytics outlining the performance and outlook of Cravatex Ltd.‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 56.598 Cr Rs. 50.68 Cr Rs. 25.776 Cr -49.14 % -54.46 %
Expenses Rs. 56.42 Cr Rs. 52.56 Cr Rs. 28.1 Cr -46.54 % -50.19 %
Operating Profit Rs. 0.18 Cr Rs. -1.88 Cr Rs. -2.32 Cr -23.4 % -1388.89 %
OPM % 0.32 % -3.71 % -9 % -5.29 % -9.32 %
Other Income Rs. 1.578 Cr Rs. 2.678 Cr Rs. 3.479 Cr + 29.91 % + 120.47 %
Interest Rs. 0.08 Cr Rs. 0.11 Cr Rs. 0.11 Cr + 0 % + 37.5 %
Depreciation Rs. 0.47 Cr Rs. 0.39 Cr Rs. 0.34 Cr -12.82 % -27.66 %
Profit before tax Rs. 1.21 Cr Rs. 0.3 Cr Rs. 0.71 Cr + 136.67 % -41.32 %
Tax % 64.78 % 68 % 30.76 % -37.24 % -34.02 %
Net Profit Rs. 0.42 Cr Rs. 0.5 Cr Rs. 0.48 Cr -4 % + 14.29 %
EPS in Rs Rs. 1.64 Rs. 1.95 Rs. 1.87 -4.1 % + 14.02 %


Today, we’re looking at Cravatex Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -54.46 %. However, it did see a marginal slip of -49.14 % from the previous quarter. Expenses decreased slightly by -46.54 % quarter-on-quarter, aligning with the annual decline of -50.19 %. Operating profit, while down -1388.89 % compared to last year, faced a quarter-on-quarter dip of -23.4 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -9.32 %, but a shrinkage of -5.29 % sequentially. Other income rose by 29.91 % compared to the last quarter, despite an annual growth of 120.47 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year increase remains at a moderate 37.5 %. Depreciation costs fell by -12.82 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -27.66 %. Profit before tax declined annually by -41.32 % but saw an increase from the preceding quarter by 136.67 %.
Tax expenses as a percentage of profits decreased slightly by -34.02 % compared to last year, with a more notable quarter-on-quarter decrease of -37.24 %. Net profit rose by 14.29 % year-on-year but witnessed a -4 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 14.02 % but a quarterly fall of -4.1 %. In summary, Cravatex Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 56.598 Cr Rs. 50.68 Cr Rs. 25.776 Cr -49.14 % -54.46 %
Expenses Rs. 56.42 Cr Rs. 52.56 Cr Rs. 28.1 Cr -46.54 % -50.19 %
Operating Profit Rs. 0.18 Cr Rs. -1.88 Cr Rs. -2.32 Cr -23.4 % -1388.89 %
Net Profit Rs. 0.42 Cr Rs. 0.5 Cr Rs. 0.48 Cr -4 % + 14.29 %
EPS in Rs Rs. 1.64 Rs. 1.95 Rs. 1.87 -4.1 % + 14.02 %


In reviewing Cravatex Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -54.46 % year-on-year, although there was a slight dip of -49.14 % from the previous quarter. Expenses decreased by -50.19 % compared to the previous year, with a decrease of -46.54 % quarter-on-quarter. Operating Profit dropped by -1388.89 % annually, and saw a -23.4 % decrease from the last quarter.
Net Profit showed yearly increase of 14.29 %, and experienced a -4 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 14.02 % annually, however dipped by -4.1 % compared to the last quarter. In essence, while Cravatex Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

54

3-Year Profit

42

5-Year Profit

51

10-Year Profit

157

Current Price

3,820

Market Cap



The financial outlook for the company under BSE code 532406 reveals a significant five-year profit of 42 percents. This marks a notable increase to 54 percents over the last three years, indicating a strong upward trend in the company's financial health during this period. However, it's important to note that recent challenges have impacted the company's performance, leading to a trailing twelve-month loss of 42 percents. This sharp decline in profitability is particularly concerning, as the company has also reported no sales across any analyzed timeframe, suggesting a highly unconventional and perhaps risky operational approach. The company's stock prices mirror this financial volatility, with the stock trading at 112 percents over the past five years but experiencing a dramatic drop to 47 percents within the last year. Over a decade, the stock price was at 49 percents, reflecting long-term concerns regarding the company's stability and future outlook. Such performance poses questions about the sustainability of the business and whether it can rebound from these recent setbacks.

Currently valued at ₹3,820 crore, the company's stock price stands at ₹157. Over the years, it has seen significant fluctuations, with its price ranging from ₹224 / 86.0, a reflection of its sensitivity to market conditions and investor sentiment. The stock's Price-to-Earnings (P/E) ratio, currently at 65.0, suggests that it is highly valued in comparison to its earnings, possibly indicating strong future growth expectations or a high level of investor confidence. The book value per share is ₹8.09, which represents the net asset value of the company per share. The dividend yield of 0.12% provides some return to investors, though it may not be the primary attraction for those investing in the stock. The company's Return on Capital Employed (ROCE) is 47.4%, pointing to efficient use of its capital base to generate profits. The Return on Equity (ROE), at 38.7%, highlights the profitability for shareholders. The company's financial health is further underscored by its very low debt-to-equity ratio of 0.09, signaling conservative financial management. However, the net cash flow is negative at ₹0.86 crore, indicating possible liquidity concerns or heavy investment. The Piotroski score of 8.00 provides a snapshot of its financial stability, while the Graham Number, estimated at ₹21.0, offers an intrinsic value benchmark. With a Price-to-Book (P/B) ratio of 19.4, the stock seems to be trading at a premium relative to its book value, which could signal strong market expectations or overvaluation risks.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post